Aura Biosciences, Inc. - Common Stock (AURA)

CUSIP: 05153U107

Q3 2022 13F Holders as of 30 Sep 2022

Holder snapshot 6 signals
Share change
+517,530
SEC-reported price per share
$18.12
Number of holders
43
Value change
+$9,714,465
Number of buys
24
Number of sells
12
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
103,767,237

Security key

05153U107

Report period

Q3 2022

Institutions

43

Top holders

10

Ownership snapshot

Top reported holders of AURA - Aura Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Medicxi Ventures Manageme...
Disclosed value leader
Matrix Capital Management...
Comparable rows
0/15
Latest evidence
30 Jun 2022
13F 3/4/5 Highest disclosed value: $58,279,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Matrix Capital Management Company, LP has the largest disclosed position value at $58.28M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Matrix Capital Management Company, LP's linked filing trail.
Disclosed position value Top 5
Medicxi Ventures Management (Jers... $43.08M
Matrix Capital Management Company... $58.28M
CITADEL ADVISORS LLC $32.76M
ADAGE CAPITAL PARTNERS GP, L.L.C. $18.09M
Rock Springs Capital Management LP $14.3M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Medicxi Ventures Management (Jersey) Ltd
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$43,075,000
3,039,892 shares
— 30 Jun 2022
Matrix Capital Management Company, LP
13F
Company
13F
—
denominator unverified
$58,279,000
4,112,870 shares
— 30 Jun 2022
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$32,763,000
2,312,159 shares
— 30 Jun 2022
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
13F
—
denominator unverified
$18,090,000
1,276,619 shares
— 30 Jun 2022
Rock Springs Capital Management LP
13F
Company
13F
—
denominator unverified
$14,295,000
1,008,814 shares
— 30 Jun 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$12,566,000
886,723 shares
— 30 Jun 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
43
Shares
16,317,002
Rows available
43
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2022 vs Q4 2025 Across Filers

Q4 2025 holders
116
Q3 2022 holders
43
Holder diff
-73
Investor Q4 2025 Shares Q3 2022 Shares Share Diff Share Chg % Q4 2025 value Q3 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .